Premas Biotech and Oramed announce oral COVID-19 Vaccine candidate that produces antibodies after a single dose

Premas Biotech and Oramed announce oral COVID-19 Vaccine candidate that produces antibodies after a single dose

Premas Biotech, a developer of novel biotherapeutic and vaccine candidates, announced the development of an oral COVID-19 vaccine that has shown efficacy after a single dose, in conjunction with Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210319005359/en/ Accelerating the vaccine's path to market, Premas, Oramed and other [“¦]